![Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd](https://c8.alamy.com/comp/2CP63XG/johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-c-and-actelion-ceo-and-founder-jean-paul-clozel-r-attend-a-news-conference-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reutersarnd-wiegmann-2CP63XG.jpg)
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd
![51 Blues Band | Bern | Chicago Blues aus Bern | Schweiz - 51 Fifty One Blues Band | Chicago Blues aus Bern | Schweiz 51 Blues Band | Bern | Chicago Blues aus Bern | Schweiz - 51 Fifty One Blues Band | Chicago Blues aus Bern | Schweiz](https://image.jimcdn.com/app/cms/image/transf/dimension=2060x10000:format=jpg/path/s4cc4bdc766688c78/image/i4903fcbcadf649b7/version/1633301527/image.jpg)
51 Blues Band | Bern | Chicago Blues aus Bern | Schweiz - 51 Fifty One Blues Band | Chicago Blues aus Bern | Schweiz
![Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann](https://c8.alamy.com/comp/2CK5F4T/johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-l-and-actelion-ceo-and-founder-jean-paul-clozel-attend-a-news-conference-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reutersarnd-wiegmann-2CK5F4T.jpg)
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
![Jean Nouvels Konzert- und Kongresshaus in Luzern strahlt schöner denn je - Projekte - baunetz interior|design Jean Nouvels Konzert- und Kongresshaus in Luzern strahlt schöner denn je - Projekte - baunetz interior|design](https://cdn.baunetz-id.de/fm/1199/thumbnails/KKL_Luzern_Pilatus_940.jpg.3027086.jpg)
Jean Nouvels Konzert- und Kongresshaus in Luzern strahlt schöner denn je - Projekte - baunetz interior|design
![Image ID 159835, Lou Johnson, Bern ePrix, FIA Formula E, Jean-Eric Vergne, DS TECHEETAH, Bern, Switzerland, 22/06/2019 20:00:56 Image ID 159835, Lou Johnson, Bern ePrix, FIA Formula E, Jean-Eric Vergne, DS TECHEETAH, Bern, Switzerland, 22/06/2019 20:00:56](https://spacesuitcollections.com/images/159835_Lou_Johnson_Bern_ePrix_FIA_Formula_E_Jean-Eric_Vergne_DS_TECHEETAH_Bern_Switzerland_22_06_2019.jpg)